University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 18 of 35
Integrative Approaches for Cancer Survivorship 2: Project 2
NCT02897544
Nuevo Amanecer II: Translating a Stress Management Program for Latinas
NCT02931552
Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers
NCT02731638
Ultra Dual-Energy X-ray Absorptiometry (DXA): Accurate and Precise Quantitative Multi-compartment Body Composition
NCT03430323
Objective Assessment of Physical Activity During Chemotherapy for Breast Cancer
NCT03045575
Computerized Substance Use and Depression Screening and Behavioral Treatment in HIV Primary Care
NCT03217058
Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?
NCT02846233
The Moms Online Video Exercise Study
NCT02805140
N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI
NCT02791945
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
NCT02533934
Health-E You: Reducing Unintended Pregnancies Among Hispanic Adolescents
NCT02847858
Bococizumab HIV Evaluation (B-HIVE) Study
NCT02524106
Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients
NCT02617407
Feasibility And Efficacy Of An iPad-Based Cognitive Rehabilitation Program In Brain Tumor Patients
NCT02783495
CHAMP: A Randomized Controlled Trial of High-intensity Aerobic and Resistance Exercise for Metastatic Prostate Cancer
NCT02613273
Single Cell Genomics of Psoriatic Skin
NCT02929745
Paired Integrative Exercise Program for People With Dementia and Caregivers
NCT02729311
Exercise Intervention in Liver Transplant Patients
NCT02367092
Quality of Life in Kidney Stone Patients Undergoing Surgery
NCT02625051
Arista for ALT Donor Sites to Reduce Drain Output
NCT02477774
SFGH Health Advocates Stage II Study
NCT02746393
Immobilization of Postoperative Distal Radius Fractures
NCT02802774
Active Surveillance Exercise Clinical Trial
NCT02435472
Evaluating Multivariate MRI Maps of Body Awareness
NCT03344081
Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort
NCT02910037
Effect of Betaine and Food on Gastric pH
NCT02758015
Ahmed Glaucoma Valve Surgery With Mitomycin-C
NCT02805257
Bevacizumab Therapy for Brain Arteriovenous Malformation
NCT02314377
Cigarette Reduction Using the Quitbit Digital Lighter and Mobile Application for Smoking Cessation: a Randomized Controlled Trial
NCT02515500
A Study of Dorsal Versus Ventral Buccal Mucosa Graft Onlay for Bulbar Urethroplasty
NCT02634619
CRUSH-PrEP for Women Project
NCT02852226
Assessment of 2012 Bioequivalence Standards for Warfarin
NCT02574754
The Role of Orexin in Human Panic Disorder
NCT02593682
Cryoanalgesia vs. Epidural in the Nuss Procedure
NCT02721017
Primary Care eHealth Intervention for Improved Outcomes in Chronic Kidney Disease
NCT02097550
Programmed Intermittent Bolus Dosing Versus Continuous Epidural Infusion for Epidural Analgesia in Abdominal Surgery.
NCT03307174
A Trial of Doxycycline in Renal Disease
NCT02753426
Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD
NCT02684578
Effect of Clemastine Fumarate on Color Vision in Healthy Controls
NCT02613091
THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease
NCT02719665
Clinical Trial of NAC in Asthma
NCT02605824
Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant
NCT02429869
Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging
NCT02807779
The Effects of Oxytocin on Startle Hyperreactivity in Patients With AUD and PTSD
NCT02469259
A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis
NCT02710214
A Mindfulness Mobile Intervention Targeting Reductions in Food Cravings
NCT02694731
The Effect of a Novel Audit and Feedback Bundle on Inpatient Performance
NCT02593253
Study of Refeeding to Optimize iNpatient Gains
NCT02488109
Treatment of Incontinence Without Memory Problems
NCT02436889
Effect of Location of Tetanic Stimuli on Photoplethysmogram Under General Anesthesia
NCT05899686
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.